Clinical Trial Update: Post Market Clinical Evaluation of Gamma 4

View source ↗

Summary

Post-market clinical evaluation of the Gamma 4 device for femoral fracture has completed, with the sponsor listed as Stryker Trauma and Extremities.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoral Fracture

Drugs mentioned

• Gamma 4

Snippet

Sponsor: Stryker Trauma and Extremities | Conditions: Femoral Fracture | Status: COMPLETED